
--- Page 1 ---
mfi1TnsF,rj ductl, nos 8.500/3 Procedure Date. Carciuma S.ts Breast, 'nus C5 0.9 Procedure Physician:e Criterla Yt Attending Physician/Copies To: 21/11 DiagnosDiscr lu Deni/S DISQUAU UUID:982253AB-2C41-4E7A-9178-8690FF09FF78 PatIent hIstory: TCGA-BH-A1ES-01A-PR 'Redacted 1 & 2 TAKEN BY PATH DATE OF LMP DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: R BREAST CANCER POST-OP DIAGNOSIS: SAME OPERATIVE PROCEOURE: R MASTECTOMY, SENTINEL NODE BX'S CLINICAL HISTORY: I & 2 TAKEN BY PATH MATERIAL SUEMITTED: A) RIGHT SENTINEL LYMPH NODE, PROCUREMENT BY SURGICAL PROCEDURE #1 B) RIGHT SENTINEL LYMPH NODE, PROCUREMENT BY SURGICAL PROCEDURE 2 C) RIGHT AXILLARY LYMPH NODE(S), PROCUREMENT BY SURGICAL PROCEDURE D) RIGHT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE E) RIGHT SENTINEL LYMPH NODE, PROCUREMENT BY SURGICAL PROCEDURE #3 F) RIGHT SENTINEL LYMPH NODE, PROCUREMENT BY SURGICAL PROCEDURE H4 INTRAOPERATIVE CONSULTATION: FROzeN secrIon: 1) Sentinel node #1: 0.6 cm lymph node. Frozen Section diagnosis: Negative for tumor by Touch Prep and Frozen Section. 2) sentinel node #2: 0.8 cm iymph node. Frozen Section diagnosis: Negative for tumor by Touch Prep and Frozen Section. 3) Sentinel node #3: 0.8 cm iymph node. Frozen Section diagnosis: Negative fro tumor by Touch Prep. 4) Sentinel node #4: 0.6 cm iympn node. Frozen Section diagnosis: Negative for tumor by Touch Prep. consult: Mastectomy: 21.0 by 12.0 by 3.0 cm breast tissue with 13.0 by 5.5 cm skin ellipse, and blue dye at 12:00 position. Inked and sectioned revealing a 2.0 by 2.0 by 2.3 cm iight-tan, well position under nipple.. A second, 0.5 cm nodule is found inferior to'(and 2.0'cm from) first nodule. Margins free of tumor. FINAL DIAGNOSIS: AFS) RIGHT SENTINEL LYMPH NODE #1: - ONE (1) LYMPH NODE FOCALLY POSITIVE FOR METASTATIC CARCINOMA (SEE NOTE) BFS) SENTINEL LYMPH NODE #2: - ONE (1) LYMPH NODE NEGATIVE FOR TUMOR C) RIGHT AXILLARY LYMPH NODE: - ONE (1) LYMPH NODE NEGATIVE FOR TUMOR D) RIGHT BREAST: EXTENSIVE DUCTAL. FABCTNOMA IN-SITU, IMMEDIATE NUCLEAR GRADE WITH CENTRAL NECROSIS REPRESENTING 6O% OF TUMOR VOLUME: - FAT NECROSIS, HEMORRHAGE AND GRANULATION TISSUE CONSISTENT WITH BIOPSY SITE AND RESIDUAL DUCTAL CARCINOMA IN-SITU INTRAOUCTAL PAPILLOMA INTRAMAMMARY LYMPH NODE, NEGATIVE FOR TUMOR - SKIN AND NIPPLE, NOT REMARKABLE - MARGINS FREE OF TOMOR E) RIGHT SENTINEL LYMPH NODE #3: - NEGATIVE FOR TUMOR F) RIGHT SENTINEL LYMPH NODE #4: -' NEGATIVE FOR TUMOR NOTe: The metastatic focus is present in a vascular space in the capsule. AEl/AE3 and EMA are positive. AE1/AE3 and EMA on the other sentinel lymph nodes are negative. ER/PR ahd HER- 2/neu will be performed on block *di". SUPPLEMENTREPORT (ER/PR) My signature below is attestation that t have reviewed all slides and agree with the findings as noted below. IMMUNOPEROXIDASE IDENTIFICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE "D1".S DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGEN RECEPTOR (3OS) AND PROGESTERONE RECEPTOR (<IO%). THEREFORE, ESTROGEN RECEPTOR IS INTERPRETED AS BORDERLINE AND PROGESTERONE RECEPTOR AS. NEGATIVE.S PATHOLOGIS SUPPLEMENTREPORT (HER2/nEU) My signature below is attestation that I have reviewed all slides and agree with the findings as noted below. AS PER THE REQUEST QF DR.  c-erbB2 IHER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON PREVIOUS MAGEE SURGICAL  GSOCK "DI" (BREAST CANCER) USING A 1:30O DILUTION OF DAKO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF C-erbB2) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE MEMBRANE STAINING IS IDENTIFIED. THEREFORE, C-erbB2 (HER-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE O).